Effect of Aromatherapy on Pain, Anxiety and Satisfaction in Cannulation
- Conditions
- Hemodialysis Patients
- Interventions
- Other: aromatherapyOther: placebo
- Registration Number
- NCT06382701
- Lead Sponsor
- TC Erciyes University
- Brief Summary
The most active members of the healthcare professionals responsible for hemodialysis units are nurses, and they have a key role in pain, anxiety and satisfaction management as they are responsible for cannulation. Therefore, complementary and integrated practices need to be implemented based on evidence to strengthen the independent role of nurses in managing pain and anxiety.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Those who are over 18 years of age,
- Able to answer questions and communicate,
- No hearing, vision or speech impairments,
- Regularly undergoing hemodialysis three times a week,
- Having arterio-venous fistula for at least 3 months,
- Having pain during needle cannulation and scoring at least two or more points on the Visual Analogue Scale (VAS),
- Having been on hemodialysis for at least three months,
- Agreeing to participate in the study with their own consent,
- Patients who are not allergic to clove oil will be included in the study.
- Having neuropathic pain,
- Patients with arterio-venous fistula and loss of sensation of more than 50% in the extremity,
- Patients with infection in the arterio-venous fistula line,
- Patients with aneurysm or pseudoaneurysm in arterio-venous fistula,
- Patients who have used analgesic medication/s in the last 6 hours,
- Patients who have used sedative agent(s) in the last 6 hours,
- Patients who used local anesthetic agents before needle intervention will not be included in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention aromatherapy This is the group in which 0.5-1 ml of clove oil is applied as a spray to the arterio-venous fistula area, depending on the length of the fistula, ten minutes before needle cannulation in all hemodialysis sessions for four weeks in individuals receiving standard hemodialysis treatment. Placebo placebo This is the group in which 0.5-1 ml of aromatic clove, which does not contain active ingredients and is dissolved in pure water, is applied as a spray to the arterio-venous fistula area, depending on the length of the fistula, ten minutes before needle cannulation in all hemodialysis sessions for four weeks in individuals receiving standard hemodialysis treatment.
- Primary Outcome Measures
Name Time Method Visual Analog Scale (VAS) before and after the intervention, for 1 month, 12 times This scale will be used in our study to evaluate the anxiety experienced by patients before needle cannulation and the pain and satisfaction experienced after needle cannulation.
- Secondary Outcome Measures
Name Time Method State and Trait Anxiety Inventory (STAI) before and after the study, for 1 month, 2 times In our study, this scale will be used to evaluate the anxiety that patients may experience due to cannulation.
Trial Locations
- Locations (1)
Erciyes University
🇹🇷Melikgazi, Kayseri, Turkey